Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 12.82 is 179% above its 5-year average of 4.60, near the high end of its 5-year range (2.62–14.02).
As of the fiscal period ended Tuesday, June 30, 2026. 31.41% above its 12-month average of 9.76.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.82.
QUICK RATIO (ACID-TEST)
12.82
QUICK RATIO (ACID-TEST) AVG TTM
9.76
QUICK RATIO (ACID-TEST) AVG 3Y
6.80
QUICK RATIO (ACID-TEST) AVG 5Y
4.60
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+31.41%
CURRENT VS 3Y AVG
+88.55%
CURRENT VS 5Y AVG
+178.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 640 covered companies
CURRENT VS SECTOR MEDIAN
+328.83%
vs the sector median at left
Precision BioSciences, Inc.
Market Cap
$172.79M
Quick Ratio (Acid-Test)
12.82
TTM Avg
9.76
3Y Avg
6.80
5Y Avg
4.60
Market Cap
$172.90M
Quick Ratio (Acid-Test)
2.09
TTM Avg
2.02
3Y Avg
3.00
5Y Avg
2.71
Market Cap
$172.07M
Quick Ratio (Acid-Test)
7.98
TTM Avg
13.57
3Y Avg
13.59
5Y Avg
18.24
Market Cap
$175.73M
Quick Ratio (Acid-Test)
1.25
TTM Avg
2.29
3Y Avg
3.57
5Y Avg
4.16
Market Cap
$170.29M
Quick Ratio (Acid-Test)
3.00
TTM Avg
3.33
3Y Avg
2.94
5Y Avg
2.72
Market Cap
$168.70M
Quick Ratio (Acid-Test)
5.58
TTM Avg
2.96
3Y Avg
5.18
5Y Avg
6.05
Market Cap
$178.11M
Quick Ratio (Acid-Test)
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$180.82M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.25
3Y Avg
1.14
5Y Avg
1.20
Market Cap
$183.55M
Quick Ratio (Acid-Test)
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $172.79M | 12.82 | 9.76 | 6.80 | 4.60 |
| MediWound Ltd. (MDWD)vs › | $172.90M | 2.09 | 2.02 | 3.00 | 2.71 |
| Nkarta, Inc. (NKTX)vs › | $172.07M | 7.98 | 13.57 | 13.59 | 18.24 |
| Cue Biopharma, Inc. (CUE)vs › | $175.73M | 1.25 | 2.29 | 3.57 | 4.16 |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.29M | 3.00 | 3.33 | 2.94 | 2.72 |
| OptimizeRx Corp. (OPRX)vs › | $168.70M | 5.58 | 2.96 | 5.18 | 6.05 |
| Compass Therapeutics, Inc. (CMPX)vs › | $178.11M | 11.22 | 14.99 | 15.44 | 13.43 |
| Journey Medical Corporation (DERM)vs › | $180.82M | 1.41 | 1.25 | 1.14 | 1.20 |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.55M | 15.70 | 3.42 | 4.67 | 3.16 |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | 1.70 | 1.19 | 1.52 | 2.42 |
Quick Ratio
12.82
Excludes inventory
Current Ratio
12.82
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 12.82 |
| 2026-03-31 | 14.02 |
| 2025-12-31 | 13.32 |
| 2025-09-30 | 3.45 |
| 2025-06-30 | 5.18 |
| 2025-03-31 | 6.62 |
| 2024-12-31 | 6.34 |
| 2024-09-30 | 9.22 |
| 2024-06-30 | 4.37 |
| 2024-03-31 | 4.82 |
| 2023-12-31 | 2.73 |
| 2023-09-30 | 2.88 |
| 2023-06-30 | 2.62 |
| 2023-03-31 | 3.61 |
| 2022-12-31 | 3.34 |
| 2022-09-30 | 3.69 |
| 2022-06-30 | 4.59 |
| 2022-03-31 | 4.61 |
| 2021-12-31 | 4.50 |
| 2021-09-30 | 5.02 |
| 2021-06-30 | 5.19 |
| 2021-03-31 | 3.43 |
| 2020-12-31 | 2.46 |
| 2020-09-30 | 2.92 |
| 2020-06-30 | 4.00 |
| 2020-03-31 | 7.02 |
| 2019-12-31 | 7.19 |
| 2019-09-30 | 8.80 |
| 2019-06-30 | 14.46 |
| 2019-03-31 | 1.80 |
| 2018-12-31 | 8.22 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
